AI assistant
Sending…
BIOMARIN PHARMACEUTICAL INC — Director's Dealing 2022
May 7, 2022
30583_dirs_2022-05-06_13193736-2fe0-401b-aad6-6904752b7b91.zip
Director's Dealing
Open in viewerOpens in your device viewer
SEC Form 4 — Statement of Changes in Beneficial Ownership
Issuer: BIOMARIN PHARMACEUTICAL INC (BMRN)
CIK: 0001048477
Period of Report: 2022-04-29
Reporting Person: Guyer Charles Greg (EVP, Chief Technical Officer)
Non-Derivative Transactions
| Date | Security | Code | Shares | Price | A/D | Holdings After | Ownership |
|---|---|---|---|---|---|---|---|
| 2022-04-29 | Common Stock | A | 243 | $62.407 | Acquired | 52299 | Direct |
| 2022-05-04 | Common Stock | F | 3926 | $84.65 | Disposed | 48373 | Direct |
Footnotes
F1: Represents shares acquired by the reporting person on April 29, 2022, pursuant to the issuer's Employee Stock Purchase Plan.
More from BIOMARIN PHARMACEUTICAL INC
Declaration of Voting Results & Voting Rights Announcements
2026
Jun 4
Interim / Quarterly Report
2026
May 5
Report Publication Announcement
2026
May 4
M&A Activity
2026
Apr 27
M&A Activity
2026
Apr 23
Annual Report
2026
Apr 21
Director's Dealing
2026
Mar 19
Director's Dealing
2026
Mar 19
Director's Dealing
2026
Mar 19
Director's Dealing
2026
Mar 19